Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women

Clinical trial NCT05622838 · UNKNOWN

Trial details

NCT number: NCT05622838
Sponsor: Assiut University
Status: UNKNOWN
Study type: OBSERVATIONAL

alpha1 Anti-trypsin Pre-Eclampsia Intrauterine Growth Restriction

Start date: 2022-12-01
Primary completion: 2024-12-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.